艾司氯胺酮对脑类器官电生理与代谢重编程的影响
本研究利用健康对照和抑郁患者来源的iPSCs脑类器官,探究艾司氯胺酮的电生理与代谢效应。连续监测显示艾司氯胺酮显著降低动作电位频率和幅度,高浓度抑制更强且低浓度一周后部分恢复;单细胞RNA测序表明其浓度和时间依赖性调节能量代谢并诱导代谢重编程。
要点
- 艾司氯胺酮降低脑类器官动作电位频率和幅度,4小时内最明显。
- 高浓度(1.5 mg/L)抑制更强,低浓度(0.25 mg/L)一周后频率部分恢复。
- 艾司氯胺酮浓度和时间依赖性诱导代谢重编程,可能经能量代谢调控NMDAR。
核心结论
- 艾司氯胺酮可能通过能量代谢途径调节NMDAR活性与电生理,揭示其抗抑郁潜在机制。
研究设计与样本
- 研究使用健康对照和抑郁患者iPSCs来源的脑类器官,进行连续电生理监测和单细胞RNA测序。
主要发现
- 艾司氯胺酮显著降低动作电位频率和幅度,4小时内降幅最明显。
- 高浓度(1.5 mg/L)抑制效应更强,低浓度(0.25 mg/L)处理一周后动作电位频率恢复但仍低于处理前,高浓度组未观察到恢复。
- 单细胞RNA测序显示艾司氯胺酮以浓度和时间依赖方式调节能量代谢并诱导代谢重编程。
- 分别抑制氧化磷酸化和糖酵解并评估胞质Ca2+水平,提示艾司氯胺酮可能通过能量代谢途径调控NMDAR活性与电生理。
临床怎么用
- 为理解艾司氯胺酮抗抑郁机制提供人源类器官证据,提示能量代谢可能是其作用靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Esketamine, commonly used to treat treatment-resistant depression, has pharmacological mechanisms that remain incompletely understood. Brain organoids offer a human-relevant platform for investigating the cellular and molecular effects of drugs. In this study, we investigated the effects of esketamine on the electrophysiology and metabolism of brain organoids derived from iPSCs of healthy control subjects and depressed patients. Continuous monitoring revealed that esketamine treatment significantly decreased both the frequency and amplitude of action potentials, with the most pronounced reduction occurring within 4 h. High concentrations (1.5 mg/L) produced a stronger inhibitory effect, while organoids treated with a low concentration (0.25 mg/L) showed a recovery in action potential frequency after one week, although levels remained below pre-treatment values-a recovery not observed in the high-concentration group. Single-cell RNA sequencing demonstrated that esketamine modulated energy metabolism and induced metabolic reprogramming in a concentration- and time-dependent manner. Furthermore, by inhibiting oxidative phosphorylation and glycolysis separately and assessing cytosolic Ca2+ levels, we found that esketamine may regulate NMDAR activity and electrophysiology through energy metabolism pathways. These findings reveal a potential mechanism for esketamine's effects and offer new insights for clinical treatment strategies.
引用
- Li M, Duan W, Hao X, et al. Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms. Mol Psychiatry. 2025. PMID: 40885845. doi:10.1038/s41380-025-03198-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。